BioSpace News Archive

The American College of Rheumatology, in partnership with the Arthritis Foundation, released the 2019 ACR/AF Guideline for the Management of Osteoarthritis of the Hand, Hip and Knee.

Xtampza® ER Revenues Expected in the Range of $150.0 Million to $160.0 Million for 2020

10x Genomics, Inc., announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Cumberland Pharmaceuticals Inc. announced the launch of Caldolor® Injection in a ready-to-use bag that may be administered without dilution for pain relief.

Avidity Biosciences announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference being held January 13-16, 2020 in San Francisco, CA.

Leap Therapeutics, Inc. announced the closing of its previously announced equity financing to issue 1,421,801 shares of newly designated Series A mandatorily convertible preferred stock to a lead institutional investor, at a price of $10.54 per share, and an aggregate of 1,137,442 shares of newly designated Series B mandatorily convertible preferred stock to BeiGene and Perceptive Advisors, at a price of $10.55 per share.

Technavio announced its latest market research report titled global malignant mesothelioma therapeutics market 2019-2023.

Apellis Pharmaceuticals, Inc. announced that it has commenced an underwritten public offering of 7,000,000 shares of its common stock.

Galera Therapeutics, Inc. announced the first patient has been dosed in a Phase 2a clinical trial of lead product candidate avasopasem manganese to evaluate its ability to reduce the incidence of radiation-induced esophagitis in patients with lung cancer.

A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there following the presentation for 30 days.